Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Genotypic variation and antifungal susceptibilities of Candida pelliculosa clinical isolates.

Barchiesi F, Tortorano AM, Di Francesco LF, Rigoni A, Giacometti A, Spreghini E, Scalise G, Viviani MA.

J Med Microbiol. 2005 Mar;54(Pt 3):279-85.

PMID:
15713612
2.

Activity of the new antifungal triazole, posaconazole, against Cryptococcus neoformans.

Barchiesi F, Schimizzi AM, Caselli F, Giannini D, Camiletti V, Fileni B, Giacometti A, Di Francesco LF, Scalise G.

J Antimicrob Chemother. 2001 Dec;48(6):769-73.

PMID:
11733459
3.

Electrophoretic karyotyping and antifungal susceptibility patterns of Candida parapsilosis clinical isolates causing deep and superficial fungal infections.

Barchiesi F, Di Francesco LF, Arzeni D, Caselli F, Simonetti O, Cellini A, Giacometti A, Offidani AM, Scalise G.

Mycopathologia. 2001;149(3):117-21.

PMID:
11307593
4.

Interactions of posaconazole and flucytosine against Cryptococcus neoformans.

Barchiesi F, Schimizzi AM, Najvar LK, Bocanegra R, Caselli F, Di Cesare S, Giannini D, Di Francesco LF, Giacometti A, Carle F, Scalise G, Graybill JR.

Antimicrob Agents Chemother. 2001 May;45(5):1355-9.

5.

In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.

Barchiesi F, Tortorano AM, Di Francesco LF, Cogliati M, Scalise G, Viviani MA.

J Antimicrob Chemother. 1999 Feb;43(2):295-9.

PMID:
11252339
6.

Interactions between triazoles and amphotericin B against Cryptococcus neoformans.

Barchiesi F, Schimizzi AM, Caselli F, Novelli A, Fallani S, Giannini D, Arzeni D, Di Cesare S, Di Francesco LF, Fortuna M, Giacometti A, Carle F, Mazzei T, Scalise G.

Antimicrob Agents Chemother. 2000 Sep;44(9):2435-41.

7.

In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens.

Barchiesi F, Arzeni D, Fothergill AW, Di Francesco LF, Caselli F, Rinaldi MG, Scalise G.

Antimicrob Agents Chemother. 2000 Jan;44(1):226-9.

8.

Comparison of four methods for DNA typing of clinical isolates of Candida glabrata.

Di Francesco LF, Barchiesi F, Caselli F, Cirioni O, Scalise G.

J Med Microbiol. 1999 Oct;48(10):955-63.

PMID:
10510973
9.

In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans.

Barchiesi F, Gallo D, Caselli F, Di Francesco LF, Arzeni D, Giacometti A, Scalise G.

J Antimicrob Chemother. 1999 Jul;44(1):65-70.

PMID:
10459811
10.

In vitro activity of five antifungal agents against clinical isolates of Saccharomyces cerevisiae.

Barchiesi F, Arzeni D, Compagnucci P, Di Francesco LF, Giacometti A, Scalise G.

Med Mycol. 1998 Dec;36(6):437-40.

PMID:
10206757
11.

In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.

Barchiesi F, Di Francesco LF, Compagnucci P, Arzeni D, Giacometti A, Scalise G.

J Antimicrob Chemother. 1998 Jan;41(1):59-65.

PMID:
9511038
12.

Genotypic identification of sequential Candida albicans isolates from AIDS patients by polymerase chain reaction techniques.

Barchiesi F, Di Francesco LF, Compagnucci P, Arzeni D, Cirioni O, Scalise G.

Eur J Clin Microbiol Infect Dis. 1997 Aug;16(8):601-5.

PMID:
9323474

Supplemental Content

Loading ...
Support Center